Please login to the form below

Not currently logged in
Email:
Password:

Interleukin-11 inhibitor

This page shows the latest Interleukin-11 inhibitor news and features for those working in and with pharma, biotech and healthcare.

Boehringer bolsters NASH pipeline with Enleofen link-up

Boehringer bolsters NASH pipeline with Enleofen link-up

Boehringer Ingelheim has added another platform in its fibrotic disease R&D, partnering with Enleofen on preclinical-stage interleukin-11 inhibitors with potential in non-alcoholic steatohepatitis (NASH). ... The German pharma group has acquired

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....